EORTC Trial 10801

👉The EORTC Trial 10801 was a randomized multicenter trial that compared breast-conserving therapy with MRM for patients with invasive breast cancer less than 5 cm in diameter.

👉At 10 years, there was no difference between the two groups in OS or in distant metastasis-free rates.

👉Locoregional recurrence at 10 years was 12% for the mastectomy group and 20% for the breast-conserving therapy group.

#Arrangoiz #BreastCancer #BreastSurgeon #CancerSurgeon #SurgicalOncologist

Leave a comment